SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-005642
Filing Date
2021-02-12
Accepted
2021-02-12 06:03:30
Documents
67
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q ktra-10q_20201231.htm 10-Q 2610601
2 EX-31.1 ktra-ex311_10.htm EX-31.1 21541
3 EX-31.2 ktra-ex312_8.htm EX-31.2 21278
4 EX-32.1 ktra-ex321_7.htm EX-32.1 8822
5 EX-32.2 ktra-ex322_6.htm EX-32.2 8894
6 GRAPHIC gmv4cjeekwzc000001.jpg GRAPHIC 118131
7 GRAPHIC gmv4cjeekwzc000003.jpg GRAPHIC 64288
8 GRAPHIC gmv4cjeekwzc000002.jpg GRAPHIC 53637
  Complete submission text file 0001564590-21-005642.txt   8843948

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT ktra-20201231.xml EX-101.INS 1668825
10 XBRL TAXONOMY EXTENSION SCHEMA ktra-20201231.xsd EX-101.SCH 74591
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ktra-20201231_cal.xml EX-101.CAL 30172
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ktra-20201231_def.xml EX-101.DEF 279377
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE ktra-20201231_lab.xml EX-101.LAB 489367
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ktra-20201231_pre.xml EX-101.PRE 411391
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37823 | Film No.: 21622490
SIC: 2834 Pharmaceutical Preparations